Table 1.
Clinical characteristics of the Aβ+ Alzheimer’s disease group
| Demographics | All (N = 25) | PCA (N = 13) | lvPPA (N = 10) | Dysexecutive (N = 2) |
|---|---|---|---|---|
| Age (years) | 68.3 ± 8 | 67.3 ± 9.1 | 70.8 ± 6.2 | 62.5 ± 7.7 |
| Sex (M/F) | 9/16 | 3/10 | 4/6 | 2/0 |
| Education (years) | 16.5 ± 2.4 | 16.8 ± 1.9 | 15.7 ± 2.9 | 19.0 ± 1.4 |
| MoCA | 16.4 ± 5.9 | 15.2 ± 5.1 | 18.8 ± 6.1 | 12.5 ± 9.2 |
| CDR | CDR 0.5 (N = 16) CDR 1 (N = 9) |
CDR 0.5 (N = 7) CDR 1 (N = 6) |
CDR 0.5 (N = 9) CDR 1 (N = 1) |
CDR 1 (N = 2) |
| CDR-SOB | 3.7 ± 1.8 | 4.5 ± 1.6 | 2.4 ± 1.3 | 4.7 ± 0.4 |
| PiB FLR DVR | 1.9 ± 0.2 | 1.7 ± 0.3 | 1.7 ± 0.2 | 1.9 ± 0.2 |
MoCA, Montreal Cognitive Assessment; CDR, clinical dementia rating; SOB, sum of box scores; PiB FLR DVR, Pittsburgh Compound B fronto-lateral-retrosplenial distribution value ratio.